556 related articles for article (PubMed ID: 12161519)
21. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
22. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
23. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
[TBL] [Abstract][Full Text] [Related]
24. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
[TBL] [Abstract][Full Text] [Related]
27. Joint mechanisms of impaired growth-hormone pulse renewal in aging men.
Veldhuis JD; Iranmanesh A; Bowers CY
J Clin Endocrinol Metab; 2005 Jul; 90(7):4177-83. PubMed ID: 15811926
[TBL] [Abstract][Full Text] [Related]
28. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
degli Uberti EC; Ambrosio MR; Cella SG; Margutti AR; Trasforini G; Rigamonti AE; Petrone E; Müller EE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
[TBL] [Abstract][Full Text] [Related]
29. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
[TBL] [Abstract][Full Text] [Related]
30. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
[TBL] [Abstract][Full Text] [Related]
31. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
[TBL] [Abstract][Full Text] [Related]
32. Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults.
Veldhuis JD; Farhy L; Weltman AL; Kuipers J; Weltman J; Wideman L
J Clin Endocrinol Metab; 2005 May; 90(5):2874-81. PubMed ID: 15728217
[TBL] [Abstract][Full Text] [Related]
33. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
34. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
[TBL] [Abstract][Full Text] [Related]
35. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
Lanzi R; Tannenbaum GS
Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
[TBL] [Abstract][Full Text] [Related]
36. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
[TBL] [Abstract][Full Text] [Related]
37. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.
Iranmanesh A; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2004 Sep; 89(9):4581-7. PubMed ID: 15356066
[TBL] [Abstract][Full Text] [Related]
38. The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.
Bellone J; Bellone S; Aimaretti G; Valetto MR; Baffoni C; Corneli G; Origlia C; Arvat E; Ghigo E
J Endocrinol Invest; 2000 Mar; 23(3):158-62. PubMed ID: 10803472
[TBL] [Abstract][Full Text] [Related]
39. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
[TBL] [Abstract][Full Text] [Related]
40. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
Soule SG; Macfarlane P; Levitt NS; Millar RP
S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
